Stockreport

Inovio Pharmaceuticals Spotlights INO-3107 BLA Acceptance, FDA Talks Ahead of Oct. 30 PDUFA Date [Yahoo! Finance]

Inovio Pharmaceuticals, Inc.  (INO) 
NASDAQ:AMEX Investor Relations: ir.inovio.com/investors/default.aspx
PDF Inovio Pharmaceuticals (NASDAQ:INO) used an appearance at Oppenheimer's 36th Annual Life Science Conference to highlight recent regulatory progress for its lead program [Read more]